{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/ADCT/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-15T17:25:36.563Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":10343,"canonical_name":"ADC Therapeutics SA","cik":"0001771910","uei":null,"lei":null,"duns":null,"ticker":"ADCT"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":26},"count":26,"timeline":[{"ts":"2026-10-13","kind":"sec.filing","form_type":"8-K","title":"8-K — ADC Therapeutics SA — 2026-10-13","url_slug":"/sec/cik-0001771910/8-k/0000950103-26-015465","accession_number":"0000950103-26-015465","importance":35},{"ts":"2026-08-13","kind":"sec.filing","form_type":"10-Q","title":"10-Q — ADC Therapeutics SA — 2026-08-13","url_slug":"/sec/cik-0001771910/10-q/0001628280-26-056711","accession_number":"0001628280-26-056711","importance":45},{"ts":"2026-08-13","kind":"sec.filing","form_type":"8-K","title":"8-K — ADC Therapeutics SA — 2026-08-13","url_slug":"/sec/cik-0001771910/8-k/0000950103-26-012287","accession_number":"0000950103-26-012287","importance":35},{"ts":"2026-08-13","kind":"sec.filing","form_type":"S-8","title":"S-8 — ADC Therapeutics SA — 2026-08-13","url_slug":"/sec/cik-0001771910/s-8/0000950103-26-012337","accession_number":"0000950103-26-012337","importance":30},{"ts":"2026-07-27","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — ADC Therapeutics SA — 2026-07-27","url_slug":"/sec/cik-0001771910/schedule-13g/0002012383-26-002147","accession_number":"0002012383-26-002147","importance":55},{"ts":"2026-07-02","kind":"sec.filing","form_type":"8-K","title":"8-K — ADC Therapeutics SA — 2026-07-02","url_slug":"/sec/cik-0001771910/8-k/0000950103-26-010195","accession_number":"0000950103-26-010195","importance":35},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — ADC Therapeutics SA — 2026-07-02","url_slug":"/sec/cik-0001771910/4/0001628280-26-047031","accession_number":"0001628280-26-047031","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — ADC Therapeutics SA — 2026-07-02","url_slug":"/sec/cik-0001771910/4/0001628280-26-047036","accession_number":"0001628280-26-047036","importance":30},{"ts":"2026-06-30","kind":"sec.insider.a","reporter":"GRAHAM PETER J","title":"Chief Legal Officer","shares":221100,"price_per_share":0,"usd_value":0,"security_title":"Common Shares","importance":15},{"ts":"2026-06-30","kind":"sec.insider.a","reporter":"Carmona Jose","title":"Chief Financial Officer","shares":203700,"price_per_share":0,"usd_value":0,"security_title":"Common Shares","importance":15},{"ts":"2026-06-30","kind":"sec.insider.a","reporter":"MALLIK AMEET","title":"Chief Executive Officer","shares":675000,"price_per_share":0,"usd_value":0,"security_title":"Common Shares","importance":15},{"ts":"2026-06-30","kind":"sec.insider.a","reporter":"Zaki Mohamed","title":"Chief Medical Officer","shares":213900,"price_per_share":0,"usd_value":0,"security_title":"Common Shares","importance":15},{"ts":"2026-06-03","kind":"sec.filing","form_type":"8-K","title":"8-K — ADC Therapeutics SA — 2026-06-03","url_slug":"/sec/cik-0001771910/8-k/0000950103-26-008465","accession_number":"0000950103-26-008465","importance":35},{"ts":"2026-06-03","kind":"sec.insider.f","reporter":"Squarer Ron","title":null,"shares":15196,"price_per_share":3.08,"usd_value":46804,"security_title":"Common Shares","importance":15.04680368},{"ts":"2026-06-03","kind":"sec.insider.f","reporter":"Coughlin Timothy","title":null,"shares":12600,"price_per_share":3.08,"usd_value":38808,"security_title":"Common Shares","importance":15.038808},{"ts":"2026-06-03","kind":"sec.insider.f","reporter":"BIZZARI JEAN-PIERRE","title":null,"shares":12600,"price_per_share":3.08,"usd_value":38808,"security_title":"Common Shares","importance":15.038808},{"ts":"2026-06-03","kind":"sec.insider.f","reporter":"Azelby Robert","title":null,"shares":12600,"price_per_share":3.08,"usd_value":38808,"security_title":"Common Shares","importance":15.038808},{"ts":"2026-06-03","kind":"sec.insider.f","reporter":"Monges Viviane","title":null,"shares":2596,"price_per_share":3.08,"usd_value":7996,"security_title":"Common Shares","importance":15.00799568},{"ts":"2026-06-03","kind":"sec.insider.f","reporter":"Hug Peter","title":null,"shares":2156,"price_per_share":3.08,"usd_value":6640,"security_title":"Common Shares","importance":15.00664048},{"ts":"2026-06-02","kind":"sec.filing","form_type":"8-K","title":"8-K — ADC Therapeutics SA — 2026-06-02","url_slug":"/sec/cik-0001771910/8-k/0000950103-26-008321","accession_number":"0000950103-26-008321","importance":35},{"ts":"2026-06-01","kind":"sec.insider.a","reporter":"Coughlin Timothy","title":null,"shares":45000,"price_per_share":0,"usd_value":0,"security_title":"Common Shares","importance":15},{"ts":"2026-06-01","kind":"sec.insider.a","reporter":"Squarer Ron","title":null,"shares":45000,"price_per_share":0,"usd_value":0,"security_title":"Common Shares","importance":15},{"ts":"2026-06-01","kind":"sec.insider.a","reporter":"BIZZARI JEAN-PIERRE","title":null,"shares":45000,"price_per_share":0,"usd_value":0,"security_title":"Common Shares","importance":15},{"ts":"2026-06-01","kind":"sec.insider.a","reporter":"Azelby Robert","title":null,"shares":45000,"price_per_share":0,"usd_value":0,"security_title":"Common Shares","importance":15},{"ts":"2026-06-01","kind":"sec.insider.a","reporter":"Hug Peter","title":null,"shares":45000,"price_per_share":0,"usd_value":0,"security_title":"Common Shares","importance":15},{"ts":"2026-06-01","kind":"sec.insider.a","reporter":"Monges Viviane","title":null,"shares":45000,"price_per_share":0,"usd_value":0,"security_title":"Common Shares","importance":15}]}